Oxytocic Pharmaceuticals Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

 

Oxytocic Pharmaceuticals Market
Oxytocic Pharmaceuticals Market 

Oxytocic medications that increase uterine activity additionally, it controls postpartum haemorrhage. It can be infused into a vein or injected into a muscle. By taking an extract from an animal's pituitary gland, natural oxytocin can be created.

Over the projected period, an increase in childbirths induced by labour is anticipated to fuel market expansion for oxytocic medications. For instance, the National Perinatal Information Center reported in January 2019 that induction of labour rates increased by 40% in the United States between 1997 and 2017. Additionally, an increased occurrence of postpartum haemorrhage is anticipated to support market expansion.

The expansion of the worldwide oxytocic pharmaceuticals market is anticipated to be hampered by the accessibility of substitute medications. Misoprostol and magnesium sulphates are a few of oxytocic drug substitutes. Misoprostol is advised by the World Health Organization (WHO) as a low-cost, scientifically supported substitute for oxytocin. Additionally, it is anticipated that oxytocin preparation quality problems may impede market expansion. A number of producers fail to get WHO prequalification before producing oxytocin products, which results in the market introduction of medications of inferior quality.

 

Comments

Popular posts from this blog

The Role of the Foodservice Industry in Driving the French Fries Market

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

The Growing Demand for Healthcare Staffing Market: Trends and Opportunities